Block listing Interim Review

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

SOP: 792,700 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 0 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 792,700 ordinary shares of 10 pence

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

LTIP: 102,714 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

LTIP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

LTIP: 15,014 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

LTIP: 87,700 ordinary shares of 10 pence

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

MIP: 770,393 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

MIP: 1,000,000 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

MIP: 8,391 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

MIP: 1,519,989 ordinary shares of 10 pence

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From:

1 October 2019

To:

31 March 2020

Balance of unallotted securities under scheme(s) from previous return:

EIP: 1,541,128 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

EIP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

EIP: 8,742 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

EIP: 1,102,558 ordinary shares of 10 pence

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772